Table 3 Clinical outcomes after trabectedin therapy
Pt no. | Best RECIST response | PFS (months) | Progression | OS (months) | Status at last follow-up | GMI = TTP2/TTP1 | ||
|---|---|---|---|---|---|---|---|---|
TTP1 (months) | TTP2 (months) | GMI | ||||||
1 | SD | 11.7 | N | 11.7 | Alive | 4.9 | - | - |
2 | SD | 11.6 | Y | 29.2 | Alive | 5.6 | 11.6 | 2.07 |
3 | SD | 3.8 | Y | 9.1 | Dead | 1.9 | 3.8 | 2.02 |
4 | SD | 14.6 | Y | 22.3 | Dead | 12.6 | 14.6 | 1.16 |
5 | SD | 30.9 | N | 30.8 | Alive | 7.1 | - | - |
6 | SD | 11.0 | Y | 20.9 | Alive | 3.1 | 11.0 | 3.61 |
7 | PD | 1.9 | Y | 7.0 | Dead | 18.7 | 1.9 | 0.11 |
8 | PR | 7.5 | Y | 23.4 | Dead | 5.1 | 7.5 | 1.49 |
9 | PD | 2.0 | Y | 11.1 | Dead | 7.7 | 2.0 | 0.26 |
10 | SD | 15.2 | Y | 17.7 | Dead | 25.3 | 15.2 | 0.6 |
11 | SD | 12.3 | Y | 74.2 | Alive | 3.0 | 12.3 | 4.12 |
Median | Â | 11.6 | Â | 22.3 | Â | 5.6 | 11.6 | 1.49 |